Hypoxia-inducible factor-1α and vascular endothelial growth factor in the cardioprotective effects of intermittent hypoxia in rats
暂无分享,去创建一个
[1] Liang-Yi Si,et al. Obstructive sleep apnea syndrome (OSAS) and hypertension: Pathogenic mechanisms and possible therapeutic approaches , 2012, Upsala journal of medical sciences.
[2] A. Coran,et al. Dietary L-arginine supplementation reduces Methotrexate-induced intestinal mucosal injury in rat , 2012, BMC Gastroenterology.
[3] J. Park,et al. Silver nanoparticles modify VEGF signaling pathway and mucus hypersecretion in allergic airway inflammation , 2012, International journal of nanomedicine.
[4] B. Viollet,et al. Nicotinamide phosphoribosyltransferase protects against ischemic stroke through SIRT1‐dependent adenosine monophosphate–activated kinase pathway , 2011, Annals of neurology.
[5] K. Pritchard,et al. The protective role of intestinal alkaline phosphatase in necrotizing enterocolitis. , 2010, The Journal of surgical research.
[6] H. Scharfman,et al. Protective role of aquaporin‐4 water channels after contusion spinal cord injury , 2010, Annals of neurology.
[7] A. Ivanina,et al. Effects of cadmium exposure and intermittent anoxia on nitric oxide metabolism in eastern oysters, Crassostrea virginica , 2010, Journal of Experimental Biology.
[8] S. Powell,et al. The ubiquitin-proteasome system in myocardial ischaemia and preconditioning. , 2010, Cardiovascular research.
[9] F. Holsboer,et al. Depletion of the neural precursor cell pool by glucocorticoids , 2010, Annals of neurology.
[10] C. Chien,et al. Repetitive Hypoxic Preconditioning Attenuates Renal Ischemia/Reperfusion Induced Oxidative Injury via Upregulating HIF-1&agr;–Dependent bcl-2 Signaling , 2009, Transplantation.
[11] M. Derrick,et al. Tetrahydrobiopterin in the prevention of hypertonia in hypoxic fetal brain , 2009, Annals of neurology.
[12] D. Lefer,et al. Protective ischaemia in patients: preconditioning and postconditioning. , 2009, Cardiovascular research.
[13] N. Barbaro,et al. Soluble endoglin modulates aberrant cerebral vascular remodeling , 2009, Annals of neurology.
[14] Gabriel G. Haddad,et al. Distinct Mechanisms Underlying Tolerance to Intermittent and Constant Hypoxia in Drosophila melanogaster , 2009, PloS one.
[15] P. Lévy,et al. Major role for hypoxia inducible factor-1 and the endothelin system in promoting myocardial infarction and hypertension in an animal model of obstructive sleep apnea. , 2009, Journal of the American College of Cardiology.
[16] J. Simpkins,et al. Intermittent hypoxia conditioning prevents behavioral deficit and brain oxidative stress in ethanol-withdrawn rats. , 2008, Journal of applied physiology.
[17] Michael L. Smith,et al. Intermittent Hypoxia: Cause of or Therapy for Systemic Hypertension? , 2008, Experimental biology and medicine.
[18] P. Schumacker,et al. Role of hypoxia-inducible factor in cell survival during myocardial ischemia–reperfusion , 2008, Cell Death and Differentiation.
[19] S. Bertuglia. Intermittent hypoxia modulates nitric oxide-dependent vasodilation and capillary perfusion during ischemia-reperfusion-induced damage. , 2008, American journal of physiology. Heart and circulatory physiology.
[20] B. Buchholz,et al. HIF activation protects from acute kidney injury. , 2008, Journal of the American Society of Nephrology : JASN.
[21] B. Walker,et al. Eucapnic intermittent hypoxia augments endothelin-1 vasoconstriction in rats: role of PKCdelta. , 2008, American journal of physiology. Heart and circulatory physiology.
[22] David T. Shima,et al. Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury. , 2007, The American journal of pathology.
[23] P. Clavien,et al. Improving outcome in patients undergoing liver surgery , 2007, Liver international : official journal of the International Association for the Study of the Liver.
[24] Max Costa,et al. Hypoxia-Inducible Factor-1 (HIF-1) , 2006, Molecular Pharmacology.
[25] Myoung-Gwi Ryou,et al. β1-Adrenergic receptor antagonism abrogates cardioprotective effects of intermittent hypoxia , 2006, Basic Research in Cardiology.
[26] E. Manukhina,et al. Role of Nitric Oxide in Cardiovascular Adaptation to Intermittent Hypoxia , 2006, Experimental biology and medicine.
[27] M. Cacchio,et al. HIF‐1α cytoplasmic accumulation is associated with cell death in old rat cerebral cortex exposed to intermittent hypoxia , 2005, Aging cell.
[28] P. Lévy,et al. Chronic intermittent hypoxia increases infarction in the isolated rat heart. , 2005, Journal of applied physiology.
[29] K. Alitalo,et al. The biology of vascular endothelial growth factors. , 2005, Cardiovascular research.
[30] H. Ding,et al. Intermittent hypoxia protects the rat heart against ischemia/reperfusion injury by activating protein kinase C. , 2004, Life sciences.
[31] D. Ansley,et al. Antioxidant therapy with Salvia miltiorrhiza decreases plasma endothelin-1 and thromboxane B2 after cardiopulmonary bypass in patients with congenital heart disease. , 2003, The Journal of thoracic and cardiovascular surgery.
[32] H. Ding,et al. ATP-dependent potassium channels involved in the cardiac protection induced by intermittent hypoxia against ischemia/reperfusion injury. , 2003, Life sciences.
[33] N. Ferrara,et al. The biology of VEGF and its receptors , 2003, Nature Medicine.
[34] L. Ho,et al. Neuroprotective Effect of Intermittent Hypoxia on Iron-Induced Oxidative Injury in Rat Brain , 2002, Experimental Neurology.
[35] Y. Taniyama,et al. Angiogenesis and Antifibrotic Action by Hepatocyte Growth Factor in Cardiomyopathy , 2002, Hypertension.
[36] Y. Taniyama,et al. Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat and rabbit hindlimb ischemia models: preclinical study for treatment of peripheral arterial disease , 2001, Gene Therapy.
[37] G. Semenza,et al. Role of hypoxia‐inducible factor‐1 in hypoxia‐induced ischemic tolerance in neonatal rat brain , 2000, Annals of neurology.
[38] G Baumgarten,et al. Endogenous tumor necrosis factor protects the adult cardiac myocyte against ischemic-induced apoptosis in a murine model of acute myocardial infarction. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[39] G. Semenza. HIF-1: mediator of physiological and pathophysiological responses to hypoxia. , 2000, Journal of applied physiology.
[40] J. Piiper,et al. Effect of chronic hypoxia on hemodynamics, organ blood flow and O2 supply in rats. , 1993, Respiration physiology.
[41] R. Jennings,et al. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. , 1986, Circulation.
[42] C. Balke,et al. Left ventricular dysfunction and associated cellular injury in rats exposed to chronic intermittent hypoxia. , 2008, Journal of applied physiology.
[43] O. Novakova,et al. Role of oxidative stress in PKC-δ upregulation and cardioprotection induced by chronic intermittent hypoxia , 2007 .
[44] S. Scharf,et al. Chronic intermittent hypoxia increases sympathetic responsiveness to hypoxia and hypercapnia. , 1999, Journal of applied physiology.
[45] M. Fishbein,et al. Experimental myocardial infarction in the rat: qualitative and quantitative changes during pathologic evolution. , 1978, The American journal of pathology.
[46] Judith A. Neubauer. highlighted topics Physiological and Genomic Consequences of Intermittent Hypoxia Invited Review: Physiological and pathophysiological responses to intermittent hypoxia , 2022 .
[47] K. Fagan,et al. highlighted topics Physiological and Genomic Consequencesof Intermittent Hypoxia Selected Contribution: Pulmonary hypertension in mice following intermittent hypoxia , 2001 .